These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28194580)

  • 21. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
    Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H
    J Med Virol; 2010 Aug; 82(8):1355-63. PubMed ID: 20572071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.
    Baćak V; Laušević D; Mugoša B; Vratnica Z; Terzić N
    Eur Addict Res; 2013; 19(2):68-73. PubMed ID: 23006531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
    Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
    Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
    Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
    J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.
    van Asten L; Verhaest I; Lamzira S; Hernandez-Aguado I; Zangerle R; Boufassa F; Rezza G; Broers B; Robertson JR; Brettle RP; McMenamin J; Prins M; Cochrane A; Simmonds P; Coutinho RA; Bruisten S;
    J Infect Dis; 2004 Jan; 189(2):292-302. PubMed ID: 14722895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology of hepatitis C virus in a social network of injection drug users.
    Aitken CK; McCaw RF; Bowden DS; Tracy SL; Kelsall JG; Higgs PG; Kerger MJ; Nguyen H; Crofts JN
    J Infect Dis; 2004 Nov; 190(9):1586-95. PubMed ID: 15478062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.
    Paintsil E; Verevochkin SV; Dukhovlinova E; Niccolai L; Barbour R; White E; Toussova OV; Alexander L; Kozlov AP; Heimer R
    Addiction; 2009 Nov; 104(11):1881-90. PubMed ID: 19712125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.
    Trimbitas RD; Fayssel N; Serghini FZ; Wakrim L; Khyatti M; Essalhi M; Bellefquih AM; Benani A
    J Med Virol; 2016 Aug; 88(8):1376-83. PubMed ID: 26754854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use.
    Kalinina O; Norder H; Vetrov T; Zhdanov K; Barzunova M; Plotnikova V; Mukomolov S; Magnius LO
    J Med Virol; 2001 Nov; 65(3):517-24. PubMed ID: 11596087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province.
    Wang M; Liao Q; Xu R; Song D; Huang J; You Q; Shan Z; Huang K; Rong X; Fu Y
    Arch Virol; 2019 Jul; 164(7):1761-1770. PubMed ID: 31065852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary characteristics and immune mutation of hepatitis C virus genotype 1b among intravenous drug users in mainland, China.
    Wu S; Yuan H; Fan H; Xu Y; Liu Z; Wu X; Wu M; Zhang X; Shi T; Zhang T
    J Viral Hepat; 2022 Mar; 29(3):209-217. PubMed ID: 35075775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients.
    Salehi Moghadam F; Mohebbi SR; Hosseini SM; Romani S; Mirtalebi H; Azimzadeh P; Damavand B; Naghoosi H; Khanyaghma M; Sanati A; Zali MR
    J Med Virol; 2014 Aug; 86(8):1342-9. PubMed ID: 24838700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus molecular epidemiology in Uzbekistan.
    Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
    J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.
    Lopes CL; Teles SA; Espírito-Santo MP; Lampe E; Rodrigues FP; Motta-Castro AR; Marinho TA; Reis NR; Silva AM; Martins RM
    Rev Saude Publica; 2009 Aug; 43 Suppl 1():43-50. PubMed ID: 19669064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region.
    Driesel G; Wirth D; Stark K; Baumgarten R; Sucker U; Schreier E
    Arch Virol; 1994; 139(3-4):379-88. PubMed ID: 7832643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic variants of hepatitis C virus in HIV-infected drug users].
    Bobkova MR; Samokhvalov EI; Kravchenko AV; Salamov GG; Zverev SIa; Pokrovskiĭ VV; L'vov DK
    Vopr Virusol; 2002; 47(3):15-20. PubMed ID: 12173428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
    Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
    J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.
    Lu L; Wang M; Xia W; Tian L; Xu R; Li C; Wang J; Rong X; Xiong H; Huang K; Huang J; Nakano T; Bennett P; Zhang Y; Zhang L; Fu Y
    J Virol; 2014 Jul; 88(13):7120-9. PubMed ID: 24719413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.